Literature DB >> 23661099

The dopamine receptor D1 gene is associated with the length of interval between first heroin use and onset of dependence in Chinese Han heroin addicts.

Sufang Peng1, Jiang Du, Haifeng Jiang, Yingmei Fu, Hanhui Chen, Haiming Sun, Dongxiang Wang, Shunying Yu, Min Zhao.   

Abstract

Previous researches showed that the dopamine receptor D1 (DRD1) may play a critical role in drug dependence. This research aimed to determine whether DRD1 played a role in development of heroin dependence in Chinese heroin-dependent patients. 465 Chinese Han heroin-dependent subjects and 379 healthy controls were recruited in the Shanghai region. Five single-nucleotide-polymorphisms (SNPs) of the DRD1 gene were genotyped in all subjects. The results found that the frequencies of DRD1 SNP genotypes or haplotypes were not different between heroin-dependent patients and controls. Among heroin-dependent patients, subjects with rs5326CC and/or rs6882300AA genotypes develop to heroin-dependent more rapidly than those without rs5326CC and/or rs6882300AA genotypes. The results indicated that DRD1 gene polymorphism may not play an important role in the susceptibility of heroin dependence in the Chinese Han population, but it may be associated with the rapidity of heroin dependence development from first drug use.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23661099     DOI: 10.1007/s00702-013-1029-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  34 in total

1.  Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.

Authors:  James K Rowlett; Donna M Platt; Wei-Dong Yao; Roger D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2007-03-09       Impact factor: 4.030

2.  A haplotype of the DRD1 gene is associated with alcohol dependence.

Authors:  P Batel; H Houchi; M Daoust; N Ramoz; M Naassila; P Gorwood
Journal:  Alcohol Clin Exp Res       Date:  2008-03-13       Impact factor: 3.455

3.  Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

Authors:  G V Williams; P S Goldman-Rakic
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

4.  Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.

Authors:  W J Berglind; J M Case; M P Parker; R A Fuchs; R E See
Journal:  Neuroscience       Date:  2005-11-14       Impact factor: 3.590

5.  Stress-induced depressive behaviors are correlated with Par-4 and DRD2 expression in rat striatum.

Authors:  Xiongzhao Zhu; Sufang Peng; Sheng Zhang; Xiuwu Zhang
Journal:  Behav Brain Res       Date:  2011-05-08       Impact factor: 3.332

Review 6.  Genetics of dopamine receptors and drug addiction: a comprehensive review.

Authors:  Bernard Le Foll; Alexandra Gallo; Yann Le Strat; Lin Lu; Philip Gorwood
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

7.  The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction.

Authors:  Michael M Vanyukov; Brion S Maher; Bernie Devlin; Galina P Kirillova; Levent Kirisci; Ling-Mei Yu; Robert E Ferrell
Journal:  Psychiatr Genet       Date:  2007-12       Impact factor: 2.458

8.  Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues.

Authors:  Jennifer M Bossert; Gabriela C Poles; Kristina A Wihbey; Eisuke Koya; Yavin Shaham
Journal:  J Neurosci       Date:  2007-11-14       Impact factor: 6.167

9.  Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts.

Authors:  G Gerra; S Bertacca; A Zaimovic; M Pirani; B Branchi; M Ferri
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

10.  5' UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholism.

Authors:  Dai-Jin Kim; Byung Lae Park; Sujung Yoon; Hae-Kook Lee; Keun-Ho Joe; Young-Hoon Cheon; Do-Hoon Gwon; Sung-Nam Cho; Hye Won Lee; Suk NamGung; Hyoung Doo Shin
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

View more
  8 in total

1.  Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.

Authors:  Orna Levran; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Ann Hum Genet       Date:  2015-02-27       Impact factor: 1.670

2.  Heroin delay discounting and impulsivity: Modulation by DRD1 genetic variation.

Authors:  Tabitha E H Moses; Margit Burmeister; Mark K Greenwald
Journal:  Addict Biol       Date:  2019-06-13       Impact factor: 4.280

3.  Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction.

Authors:  Huihui Ji; Xuting Xu; Guili Liu; Huifen Liu; Qinwen Wang; Wenwen Shen; Longhui Li; Xiaohu Xie; Haochang Hu; Lei Xu; Wenhua Zhou; Shiwei Duan
Journal:  Exp Ther Med       Date:  2017-12-12       Impact factor: 2.447

4.  Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).

Authors:  Kenneth Blum; Marlene Oscar-Berman; Zsolt Demetrovics; Debmalya Barh; Mark S Gold
Journal:  Mol Neurobiol       Date:  2014-05-31       Impact factor: 5.590

5.  Methadone Dosage and Plasma Levels, SNPs of OPRM1 Gene and Age of First Drug Use Were Associated With Outcomes of Methadone Maintenance Treatment.

Authors:  Sufang Peng; Haifeng Jiang; Jiang Du; Shuxing Lin; Shujun Pan; Shunying Yu; Min Zhao
Journal:  Front Genet       Date:  2018-10-29       Impact factor: 4.599

6.  Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors.

Authors:  Kenneth Blum; Marjorie C Gondré-Lewis; David Baron; Panayotis K Thanos; Eric R Braverman; Jennifer Neary; Igor Elman; Rajendra D Badgaiyan
Journal:  Front Psychiatry       Date:  2018-11-27       Impact factor: 4.157

7.  Evidence of CNIH3 involvement in opioid dependence.

Authors:  E C Nelson; A Agrawal; A C Heath; R Bogdan; R Sherva; B Zhang; R Al-Hasani; M R Bruchas; Y-L Chou; C H Demers; C E Carey; E D Conley; A K Fakira; L A Farrer; A Goate; S Gordon; A K Henders; V Hesselbrock; M Kapoor; M T Lynskey; P A F Madden; J A Moron; J P Rice; N L Saccone; S G Schwab; F L Shand; A A Todorov; L Wallace; T Wang; N R Wray; X Zhou; L Degenhardt; N G Martin; A R Hariri; H R Kranzler; J Gelernter; L J Bierut; D J Clark; G W Montgomery
Journal:  Mol Psychiatry       Date:  2015-08-04       Impact factor: 15.992

Review 8.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.